Literature DB >> 16873820

Clinical observations of exenatide treatment.

Allen B King, Gary Wolfe, Susan Healy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16873820     DOI： 10.2337/dc06-0864

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  5 in total

1.  Serum Vitamin D Level among Multiple Sclerosis Patients in the Tropics: Experience from a Private Clinic in Addis Ababa, Ethiopia.

Authors:  Biniyam A Ayele; Mehila Z Wuhib; Betesaida G Zenebe; Guta Z Metaferia
Journal:  Ethiop J Health Sci       Date:  2021-05

2.  Clinical experience with exenatide in predominantly Asian and Pacific Islander patients with type 2 diabetes.

Authors:  Nalurporn Chokrungvaranon; Teera Chentanez; Richard F Arakaki
Journal:  Endocrine       Date:  2008-02-12       Impact factor: 3.633

3.  Emerging role of GLP-1 receptor agonists in the treatment of obesity.

Authors:  Lisa M Neff; Robert F Kushner
Journal:  Diabetes Metab Syndr Obes       Date:  2010-07-20       Impact factor: 3.168

4.  Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial.

Authors:  Martijn Scholte; Leo Timmers; Flip Jp Bernink; Robert N Denham; Aernout M Beek; Otto Kamp; Michaela Diamant; Anton Jg Horrevoets; Hans Wm Niessen; Weena Jy Chen; Albert C van Rossum; Niels van Royen; Pieter A Doevendans; Yolande Appelman
Journal:  Trials       Date:  2011-11-08       Impact factor: 2.279

5.  Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease.

Authors:  Alexander Harkavyi; Amjad Abuirmeileh; Rebecca Lever; Ann E Kingsbury; Christopher S Biggs; Peter S Whitton
Journal:  J Neuroinflammation       Date:  2008-05-21       Impact factor: 8.322
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.